Consensus IBEX Limited

Stocks

IBEX

BMG4690M1010

Software

Delayed Nasdaq 20:10:23 30/09/2026 +04			5-day change	1st Jan Change
43.13 ^USD	-0.58%		+1.10%	+12.96%

09-17	Ibex Insider Sold Shares Worth $395,728, According to a Recent SEC Filing	MT
09-11	IBEX Limited, Q4 2026 Earnings Call, Sep 10, 2026

Evolution of the Average Target: IBEX Limited

Evolution of the Target Price: IBEX Limited

Changes in Analyst Recommendations: IBEX Limited

dfa08a6ef475788d97a7.k2Puxhi2t_8l8csBu4LX-tM9DGHPQXU-JiH8YqokqSU.1RvDvnz__pNUtZF519aVlIlpVUy4dTp_ShmSJZ5K_0bwJ6GUfoPkuU2E8w~a63e43a80d566dfc5d97aa108f30b938

Analysts' recommendations: IBEX Limited

11-10	RBC Lifts Price Target on IBEX to $40 From $39, Keeps Sector Perform Rating	MT
12/09/25	IBEX Rallies to All-Time High Following Higher Fiscal Q4 Results	MT
12/09/25	Ibex Q4 Beat Driven by Revenue Acceleration, GenAI Adoption, RBC Says	MT
12/09/25	RBC Raises Price Target on IBEX to $39 From $31, Keeps Sector Perform Rating	MT
12/05/25	Baird Downgrades IBEX to Neutral From Outperform, $30 Price Target	MT
07/02/25	RBC Capital Adjusts Price Target on IBEX to $24 From $21, Keeps Sector Perform Rating	MT
13/09/24	RBC Raises Price Target on IBEX to $20 From $18, Keeps Sector Perform Rating	MT
19/04/24	Baird Adjusts Price Target on IBEX to $20 From $21, Maintains Outperform Rating	MT
10/11/23	RBC Lifts Price Target on IBEX to $19 From $18, Keeps Sector Perform Rating	MT
10/11/23	Piper Sandler Downgrades IBEX to Neutral From Overweight, Price Target is $17	MT
28/09/23	Baird Adjusts Price Target on IBEX to $22 From $24, Keeps Outperform Rating	MT
18/09/23	Piper Sandler Cuts Price Target on IBEX to $17 From $24, Keeps Overweight Rating	MT
14/09/23	Citigroup Adjusts Price Target on IBEX to $18 From $23, Maintains Neutral Rating	MT
14/09/23	Baird Adjusts Price Target on IBEX to $24 From $28, Maintains Outperform Rating	MT
14/09/23	Truist Securities Adjusts IBEX Price Target to $25 From $32, Maintains Buy Rating	MT
14/09/23	IBEX Downgraded by RBC to Sector Perform From Outperform, Price Target Cut to $18 From $27	MT
19/05/23	Piper Sandler Adjusts Price Target on IBEX to $24 From $32, Keeps Overweight Rating	MT
18/05/23	Citigroup Adjusts Price Target on IBEX to $23 From $30, Keeps Neutral Rating	MT
18/05/23	RBC Cuts Price Target on IBEX to $27 From $30, Citing 'Revenue Growth Pressures,' Decline in Peer Valuations; Outperform Rating Kept	MT
18/05/23	Baird Adjusts IBEX Price Target to $28 From $32, Maintains Outperform Rating	MT
16/02/23	RBC Raises Price Target on IBEX to $30 From $26, Maintains Outperform Rating	MT
06/01/23	Piper Sandler Adjusts Price Target on IBEX to $29 From $27, Maintains Overweight Rating	MT
18/11/22	Citigroup Raises Price Target on IBEX to $26 From $18, Maintains Neutral Rating	MT
16/11/22	Truist Securities Adjusts IBEX Price Target to $27 From $22, Maintains Buy Rating	MT
16/11/22	Piper Sandler Adjusts Price Target on IBEX to $27 From $20, Maintains Overweight Rating	MT

More recommendations

Application Software

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Objective/dr gap
IBEX LIMITED	-	-	-3.18%
MICROSOFT CORPORATION			+13.42%
PALANTIR TECHNOLOGIES INC.			+4.6%
ORACLE CORPORATION			+72.71%
PALO ALTO NETWORKS, INC.			+1.98%
CROWDSTRIKE HOLDINGS, INC.			-10.3%
SAP SE			+13.21%
SERVICENOW, INC.			+11.58%
FORTINET, INC.			-6.62%
APPLOVIN CORPORATION			+62.61%
Average			+16.00%
Weighted average by Cap.			+15.63%